F. Meunier

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Franḉoise Meunier, Françoise Meunier, Francoise Meunier, F Meunier, F. Meunier, François Meunier
Publication record
163 papers · 6,094 citations · H-index 39

PAPERS

Engaging European society at the forefront of cancer research and care
20237 citationsauthor #21
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
202275 citationsauthor #34
The Porto European Cancer Research Summit 2021
202111 citationsauthor #30
The European Code of Cancer Practice.
202142 citationsauthor #13
Towards a cancer mission in Horizon Europe: recommendations
202035 citationsauthor #31
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe
202023 citationsauthor #6
A right to be forgotten for cancer survivors: A legal development expected to reflect the medical progress in the fight against cancer
202027 citationsauthor #2
Diagnosis and management of male urinary tract infections: a need for new guidelines. Study from a French general practice electronic database.
202012 citationsauthor #3
How can clinical research improve European health outcomes in cancer?
201915 citationsauthor #7
Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens.
20194 citationsauthor #12
Cancer survivorship: an integral part of Europe's research agenda
2019135 citationsauthor #9
Research on cancer survivorship needs a timely frameshift, in Europe and worldwide
20181 citationsauthor #2
Call for action to end discrimination against cancer survivors
201810 citationsauthor #3
A unique research infrastructure from the European Organisation for Research and Treatment of Cancer (EORTC) to optimize long-term follow up of patients-the YOU (Your Outcome Update) protocol: Rationale, scope, design and research opportunities
20185 citationsauthor #4
1 BACKGROUND AND IMPLEMENTATION PLAN FOR THE EUROPEAN CANCER PATIENT’S BILL OF RIGHTS, 2016 (ARCHIVE) ECC Members
20170 citationsauthor #29
Diverging EU health regulations: The urgent need for co ordination and convergence
201711 citationsauthor #3
Precision Medicine: From “Omics” to Economics towards Data-Driven Healthcare - Time for European Transformation
20176 citationsauthor #3
Effect of the European Organization for Research and Treatment of Cancer (EORTC) on social life for cancer survivors in Europe.
20160 citationsauthor #3
Data from the EORTC Cancer Survivorship Task Force
20161 citationsauthor #4
Cancer in Europe: Death sentence or life sentence?
201625 citationsauthor #7
Cancer survivorship: A positive side-effect of more successful cancer treatment
201461 citationsauthor #2
A catalyst for change: the European cancer Patient's Bill of Rights.
201446 citationsauthor #7
A Bill of Rights for patients with cancer in Europe.
201434 citationsauthor #6
Academia-industry partnerships: are we ready for new models of partnership?: the point of view of the EORTC, an academic clinical cancer research organisation.
201330 citationsauthor #3
Reforming the EU environment for clinical trials: what are the challenges?
20136 citationsauthor #4
Cancer Survivorship: A Positive Side Effect of More Successful Cancer Treatment
20136 citationsauthor #4
International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
20135 citationsauthor #6
How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?
201349 citationsauthor #2
50 years of the EORTC and the central role of the EORTC Headquarters
20122 citationsauthor #11
Fifty Years of Progress Against Cancer — The European Organisation for Research and Treatment of Cancer Celebrates its Achievements
20121 citationsauthor #3
Promoting pan-European cancer research for the benefit of all cancer patients
20120 citationsauthor #3
Commentary: fifty years of the European Organisation for Research and Treatment Of Cancer (EORTC)--making the difference for the European oncology community.
20125 citationsauthor #1
Personalised medicine in oncology: questions for the next 20 years.
201227 citationsauthor #3
The European Organisation for Research and Treatment of Cancer Imaging Programme
20102 citationsauthor #4
Improving cancer outcomes through international collaboration in academic cancer treatment trials.
200958 citationsauthor #20
Facing the Challenges of the European Clinical Trials Directive – The European Organisation for Research and Treatment of Cancer Perspective
20086 citationsauthor #2
European Organization for Research and Treatment of Cancer (EORTC)
2008152 citationsauthor #2
The First European Conference on Infections in Leukaemia - ECIL1: a current perspective.
200848 citationsauthor #1
Challenges of Cancer Research in Europe — The Case of Translational Research
20061 citationsauthor #1
The Challenges of Academic Cancer Clinical Research in Europe
20051 citationsauthor #1
The European Organisation for Research and Treatment of Cancer: a unique pan-European network
20053 citationsauthor #1
Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections.
200427 citationsauthor #2
[Clinical research in Europe and its impact on cancerology--problems and opportunities].
20040 citationsauthor #1
EORTC research and development: achievements and future perspectives.
20031 citationsauthor #3
European Organisation for Research and Treatment of Cancer's point of view.
200321 citationsauthor #1
40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of Cancer.
20022 citationsauthor #1
40 years of the EORTC
200210 citationsauthor #1
Achievements and goals of the EORTC Invasive Fungal Infections Group. European Organisation for Research and Treatment of Cancer.
200210 citationsauthor #3
EORTC scientific strategy meeting 25-26 March 1999.
199911 citationsauthor #1
Caring about women and cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancers
199910 citationsauthor #11
Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC).
1999607 citationsauthor #12
The Challenge of Invasive Fungal Infection
199945 citationsauthor #2
Impact of previous aspergillosis on the outcome of bone marrow transplantation.
1998196 citationsauthor #7
Obstacles for independent transnational clinical trials in Europe
19984 citationsauthor #3
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.
1997429 citationsauthor #13
The challenges and opportunities of cancer clinical research: EORTC perspectives
19972 citationsauthor #1
Cancer research and treatment towards the 21st century : proceedings of a symposium held 26-27 April 1996, Heidelberg, Germany
19970 citationsauthor #1
Leukaemias and cancers following iodine-131 administration for thyroid cancer.
1997139 citationsauthor #7
Current topic: Trends in invasive fungal infection - Introduction
19970 citationsauthor #1
Cancer research in the European community--report from a meeting in Stockholm in 1995.
19962 citationsauthor #3
Current clinical issues on mycoses in neutropenic patients.
199611 citationsauthor #1
Special aspects related to invasive fungal infections in children with cancer.
199516 citationsauthor #3
Standard antifungal treatment, including role of alternative modalities to administer amphotericin B.
19957 citationsauthor #3
Pathogenesis of fungal infections.
19955 citationsauthor #4
Laboratory diagnosis of invasive fungal infections in patients with neoplastic diseases
199513 citationsauthor #4
Overview of invasive fungal infections and clinical presentation.
199511 citationsauthor #2
Therapeutic indications for new triazoles and potential emergence of resistance.
19951 citationsauthor #2
Impact of cytokines and growth factors in the antifungal armamentarium.
19954 citationsauthor #3
Invasive Fungal-infections in Cancer-patients - Preface
19951 citationsauthor #1
Prophylaxis of Fungal-infections
19957 citationsauthor #2
The Monitoring and Reporting of Clinical Trials
19950 citationsauthor #2
Empirical antifungal therapy.
19950 citationsauthor #3
Aspergillosis prior to bone marrow transplantation. Infectious Diseases Working Party of the EBMT and the EORTC Invasive Fungal Infections Cooperative Group.
199528 citationsauthor #6
The Treatment of Candidemia - Reply
19951 citationsauthor #1
Fluconazole in fungal infection: A review
19948 citationsauthor #3
Alternative modalities of administering amphotericin B: current issues.
199420 citationsauthor #1
The EORTC Central Office/Data Center.
19943 citationsauthor #2
Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
199461 citationsauthor #3
[Therapy of systemic candidiasis].
19942 citationsauthor #1
Therapy of Systemic Candidoses
19943 citationsauthor #1
Current issues on the prophylaxis and the management of fungal infections in leukemic patients.
19943 citationsauthor #1
Management of candidemia.
199419 citationsauthor #1
[Future directions of antimycotic therapy].
19943 citationsauthor #1
International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
199341 citationsauthor #10
Overview of Management of Fungal Infections: Part 1
19936 citationsauthor #1
Invasive fungal infections: a challenge for the nineties.
19930 citationsauthor #1
Impact of antiemetics in cancer treatment: The eortc experience
19930 citationsauthor #4
Fluconazole (Diflucan): a review.
199357 citationsauthor #2
Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence
199381 citationsauthor #4
Pneumocystis carinii pneumonia in cancer patients.
199332 citationsauthor #2
Anaerobic bacteremia in a cancer center
199313 citationsauthor #5
Wound dressing in major head and neck cancer surgery: a prospective randomized study of gauze dressing vs sterile vaseline ointment.
199312 citationsauthor #10
[European Organization for Research and Treatment of Cancer (EORTC): objectives, realizations and future perspectives].
19920 citationsauthor #1
Fungal infections in cancer patients: An international autopsy survey
1992333 citationsauthor #9
Candidemia in immunocompromised patients.
1992174 citationsauthor #1
Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centre.
199225 citationsauthor #6
Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis.
199291 citationsauthor #3
Systemic candidal infections in neonates.
19928 citationsauthor #1
Streptococcal and enterococcal bacteremia in patients with cancer.
1992151 citationsauthor #3
Pneumocystis carinii pneumonia: the pathogen, the diagnosis and recent advances in management.
19915 citationsauthor #2

TIMELINE

1954 0 citations

1975 4 citations

1976 0 citations

1979 0 citations

1983 2 citations

1984 98 citations

1986 32 citations

1987 507 citations

1988 502 citations

1989 506 citations

1990 223 citations

1991 467 citations

1992 782 citations

1993 242 citations

1994 122 citations

1995 94 citations

1996 13 citations

1997 570 citations

1998 200 citations

1999 673 citations

2002 22 citations

2003 22 citations

2004 27 citations

2005 4 citations

2006 1 citations

2008 206 citations

2009 58 citations

2010 2 citations

2012 35 citations

2013 96 citations

2014 141 citations

2016 26 citations

2017 17 citations

2018 16 citations

2019 154 citations

2020 97 citations

2021 53 citations

2022 75 citations

2023 7 citations

F. Meunier

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT